Ушбу ишга иқтибос қилган ишлар

5 та иш

Иш: Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

1. MicroRNA-enriched exosome as dazzling dancer between cancer and immune cells

   Chou‐Yi Hsu, Abdulrahman T. Ahmed, Pooja Bansal +7

   Шарҳ мақолаExtracellular vesicles in diseaseJournal of Physiology and Biochemistry20246 иқтибос

   ABIABI:AkademIndex/openalex/2024.review-article.000027

2. Molecular dynamics insights into the redox effects on PD-1/PD-L1 and PD-1/PD-L2 interactions

   Rasulbek Mashalov, Zulfizar Toshpulatova, Zhitong Chen +1

   МақолаPlasma Applications and DiagnosticsScientific Reports20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.008635

3. Enhancing Immune Cell Activation through Cold Atmospheric Plasma: Disruption of PD-1/PD-L1/PD-L2 Immune Checkpoints via Molecular Dynamics

   Mashalov Rasulbek, Zulfizar Toshpulatova, Zhitong Chen +1

   ПрепринтPlasma Applications and DiagnosticsbioRxiv (Cold Spring Harbor Laboratory)20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.preprint.000051

4. Pyroptosis-inducing nanomedicines: A dual-mode therapeutic framework for apoptosis-resistant lung cancer

   Qamar Abuhassan, Ghaleb Oriquat, R. Roopashree +5

   МақолаInflammasome and immune disordersTissue and Cell20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.002974

5. Disrupting immune silence: Noncoding RNAs targeting the programmed cell death protein 1/programmed cell death ligand 1 axis in tumor immunity

   Chou-Yi Hsu, Ahmed Hjazi, Muath Suliman +7

   МақолаCancer Immunotherapy and BiomarkersJournal of Pharmacology and Experimental Therapeutics20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.005985